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Abstract  
 The G protein-coupled GABAB receptors, constituted from GABAB1 and GABAB2 
subunits, are important regulators of neuronal excitability by mediating long lasting 
inhibition. One factor that determines receptor availability and thereby the strength of 
inhibition is regulated protein degradation. GABAB receptors are constitutively internalized 
from the plasma membrane and either recycled to the cell surface or degraded in lysosomes. 
Lys-63-linked ubiquitination mediated by the E3 ligase Mind bomb-2 (MIB2) is the signal 
that sorts GABAB receptors to lysosomes. However, it is unknown how Lys-63-linked 
ubiquitination of the receptors is regulated. Here we show that Ca2+/calmodulin-dependent 
protein kinase II (CaMKII) promotes MIB2-mediated K63-linked ubiquitination of GABAB 
receptors under physiological and pathological conditions. We found that inhibition of 
CaMKII in cultured rat cortical neurons increased cell surface GABAB receptors, whereas 
overexpression of CaMKIIβ , but not CaMKIIα, decreased receptor levels. This effect was 
conveyed by Lys-63-linked ubiquitination of GABAB1 at multiple sites mediated by the E3 
ligase MIB2. Inactivation of the CaMKII phosphorylation site on GABAB1(Ser-867) strongly 
reduced Lys-63-linked ubiquitination of GABAB receptors and increased their cell surface 
expression, whereas the phosphomimetic mutant GABAB1(S867D) exhibited strongly 
increased Lys-63-linked ubiquitination and reduced cell surface expression. Finally, 
triggering lysosomal degradation of GABAB receptors by sustained activation of glutamate 
receptors, a condition occurring in brain ischemia, was accompanied with a massive increase 
of GABAB1(Ser-867) phosphorylation-dependent Lys-63-linked ubiquitination of GABAB 
receptors. These findings indicate that CaMKIIβ-dependent K63-linked ubiquitination of 
GABAB1 at multiple sites controls sorting of GABAB receptors to lysosomes for degradation 
under physiological and pathological condition. 
Introduction 
 γ-Aminobutyric acid (GABA), the main inhibitory neurotransmitter in the brain, activates 
the heterodimeric G protein-coupled GABAB receptors, which are assembled from GABAB1 
and GABAB2 subunits. GABAB receptors are abundantly expressed in pre- and postsynaptic 
compartments of inhibitory as well as excitatory neurons to regulate their excitability (Benke 
et al., 2012). GABAB receptors are expressed by the majority of neurons and are involved in 
the regulation of virtually all important brain functions, such as neuronal network activity, 
synaptic plasticity, and neuronal development (Craig and McBain, 2014; Gaiarsa and Porcher, 
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2013; Kohl and Paulsen, 2010; Pinard et al., 2010). Accordingly, dysfunction of GABAB 
receptor signalling has been implicated in a variety of neurological disorders (Benarroch, 
2012; Bowery, 2006; Cryan and Kaupmann, 2005; Kumar et al., 2013). 
 For understanding the contribution of GABAB receptors to physiological and pathological 
mechanisms the elucidation of its regulation is essential. A main factor regulating GABAB 
receptor signalling is the dynamic control of their cell surface expression. In this respect, 
protein degradation is one important mechanism that regulates receptor availability. The two-
main cellular protein degradation systems, proteasomes and lysosomes, contribute to the 
regulation of cell surface GABAB receptors in different cellular compartments. In the 
endoplasmic reticulum (ER), the amount of newly synthesized GABAB receptors that are 
trafficked to the cell surface is determined by proteasomal degradation via the ER associated 
degradation (ERAD) machinery (Zemoura et al., 2013). The activity state of the neuron 
controls the rate of Lys-48-linked ubiquitination of the GABAB2 subunit required for 
proteasomal receptor degradation (Zemoura and Benke, 2014). In contrast, GABAB receptors 
internalized from the cell surface are degraded in lysosomes (Grampp et al., 2008, 2007; 
Hannan et al., 2011; Kantamneni et al., 2008; Vargas et al., 2008). Sorting the receptors to 
lysosomes is mediated most likely via the endosomal sorting complex required for transport 
(ESCRT) machinery (Kantamneni et al., 2008), which targets ubiquitinated membrane 
proteins to lysosomes. Accordingly, lysosomal degradation of GABAB receptors depends on 
Lys-63-linked ubiquitination of the GABAB1 subunit at multiple sites mediated by the E3 
ubiquitin ligase MIB2 (Zemoura et al., 2016). However, the mechanism that regulates Lys-
63-linked ubiquitination of GABAB1, and thereby lysosomal degradation of the receptors, was 
unknown. Here we show that phosphorylation of Ser-867 of GABAB1 by CaMKIIβ  regulates 
the extent of MIB2-mediated K63-linked ubiquitination of GABAB1 and thereby the amount 
of lysosomal degradation. 
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Results  
 CaMKIIβ  Controls Cell Surface Expression of GABAB Receptors – Sustained activation of 
glutamate receptors, which occurs in cerebral ischemia, down-regulates GABAB receptors by 
preferentially sorting constitutively internalized receptors to lysosomes for degradation 
instead of recycling them to the cell surface (Guetg et al., 2010; Kantamneni et al., 2014; 
Maier et al., 2010; Terunuma et al., 2010b). Phosphorylation of GABAB1 at Ser-867 by 
CaMKII plays a key role in this mechanism (Guetg et al., 2010). However, it was unknown 
whether CaMKII is also involved in the regulation of GABAB receptor expression under 
normal physiological conditions. Therefore, we tested whether inhibition of CaMKII by 
KN93 affects cell surface expression of GABAB receptors in cultured cortical neurons. Cell 
surface expression of GABAB receptors was monitored by staining living neurons at 4°C with 
antibodies directed against the extracellular located N-terminal domain of the receptors. We 
have previously shown that changes in the cell surface antibody staining correlated with 
changes in the signalling strength of the receptors, verifying that altered staining intensity 
reflect changes in the expression of functional receptors (Maier et al., 2014; Zemoura et al., 
2013). Surprisingly, incubation of neurons with KN93 for 5 min slightly enhanced (114 ± 
40% of control; Fig. 1A) and incubation for 7.5 min considerably increased the level of 
GABAB receptors at the cell surface (148 ± 64% of control; Fig. 1A). However, exposure 
times longer than 10 min were less effective (not shown). These results indicate that the 
expression of the receptors in the plasma membrane is indeed controlled by CaMKII even 
under basal conditions. 
 CaMKIIα and CaMKIIβ  are the main CaMKII isoforms expressed in neurons (Hell, 2014). 
We therefore tested which isoform is involved in the regulation of GABAB receptors by 
transfecting neurons with either CaMKIIα, CaMKIIβ  or their functionally inactive mutants 
(CaMKIIα(DN), CaMKIIβ(DN)) and determined cell surface expression of GABAB receptors 
using GABAB2 antibodies. While transfecting CaMKIIα or CaMKIIα(DN) did not affect cell 
surface expression of GABAB receptors, overexpression of CaMKIIβ decreased (43 ± 17% of 
EGFP transfected control neurons, Fig. 1B) and its non-functional mutant CaMKIIβ(DN) 
increased cell surface levels of receptors (186 ± 29% of EGFP transfected control neurons, 
Fig. 1B).   
 It was previously shown that CaMKII interacts with GABAB1 (Guetg et al., 2010). Next, 
we tested whether CaMKIIβ  or CaMKIIα interacts with GABAB receptors under basal 
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conditions by overexpressing either CaMKIIα or CaMKIIβ  in neurons and testing for changes 
in interaction levels with GABAB receptors using in situ PLA with antibodies against 
GABAB1 and CaMKII (Fig. 1C). Although overexpression of CaMKIIα did not affect the 
level of GABAB receptor/CaMKII interaction (PLA signal EGFP transfected control: 100 ± 
32%, CaMKIIα: 80 ± 30%) transfection of CaMKIIβ  significantly increased the extent of 
interaction (216 ± 58% of control). The interaction of CaMKIIβ  with GABAB receptors was 
activity-dependent as blocking CaMKII with KN93 reduced the interaction level in neurons 
transfected with CaMKIIβ (PLA signal: 110 ± 40% of control).  
 These results indicate that CaMKIIβ  interacts with GABAB receptors in an activity-
dependent manner to regulate the cell surface expression of the receptors. 
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Fig 1. CaMKIIβ regulates cell surface expression of GABAB  receptors. 
A, Inhibition of CaMKII activity increased cell surface expression of GABA B receptors. Neurons were incubated 
for the indicated times with the CaMKII inhibitor KN93 (10 μM) followed by determination of cell surface 
GABA B receptors expression using GABA B1  antibodies. The immunofluorescence signals of untreated control 
neurons were set to 100%. Left, representative images (scale bar: 5 μm). Right, quantification of fluorescence 
intensities. The data represent the mean ± SD of 39-43 neurons from three independent experiments. *** p< 
0.001; one way ANOVA, Dunnett’s Multiple Comparison test. B, CaMKIIβ but not CaMKIIα regulates cell 
surface expression of GABA B receptors. Cortical neurons were transfected either with EGFP (control), 
CaMKIIα, CaMKIIβ or their functionally inactive mutants CaMKIIβ(DN) or CaMKIIα(DN). Two days after 
transfection cell surface expression of GABA B receptors was assessed using GABA B2  antibodies. Transfected 
neurons were identified via the GFP-tag of transfected CaMKIIβ (not shown). Left, representative images of the 
soma of stained neurons (scale bar, 5 μm). Right, the graphs  show the quantification of fluorescence intensities. 
Fluorescence intensities for GABA B2  in EGFP transfected neurons were set to 100%. The data represent the 
mean ± SD of 26-30 neurons from three independent experiments. *** p< 0.001; one way ANOVA, Dunnett’s 
Multiple Comparison test. C, CaMKIIβ interacts with GABA B receptors in an activity-dependent manner. 
Neurons were transfected either with EGFP (control), CaMKIIα, or CaMKIIβ and tested for interaction of 
CaMKII with GABA B receptors in the presence of absence of KN93 by in situ PLA using antibodies directed 
against CaMKII and GABA B1 . Left, representative images of PLA signals (white dots) the soma of neurons 
(scale bar, 5 μm). Right, the graph shows the quantification PLA signals. The data represent the mean ± SD of 
30 neurons per condition from three independent experiments. *** p< 0.001; one way ANOVA, Dunnett’s 
Multiple Comparison test. 
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 CaMKII Triggers Sorting of GABAB Receptors to Lysosomal Degradation – It had been 
suggested that phosphorylation of GABAB1 Ser-867 by CaMKII may mediate internalization 
of the receptors (Guetg et al., 2010). We therefore tested whether inhibition of CaMKII by 
KN93 affects the internalization of GABAB receptors. However, blocking CaMKII with 
KN93 did neither affect the kinetics (half live, control: 1.2 min, KN93: 1.6 min) nor the 
extent (control: 64 ± 19%, KN93: 65 ± 20%) of receptor internalization (Fig. 2A). 
 To gain insight into the mechanism that is affected by CaMKII inhibition, we tested the co-
localization of GABAB receptors with Rab7 (marker for late endosomes and lysosomes) and 
Rab11 (marker for recycling endosomes) (Ng et al., 2012). Inhibition of CaMKII activity in 
neurons with KN93 decreased the co-localization of GABAB receptors with Rab7 (53 ± 22% 
of control; Fig. 2B) and increased the co-localization of GABAB receptors with Rab11 (117 ± 
25%, of control; Fig. 2C). Although statistically significant, the enhanced co-localization of 
GABAB receptors with Rab11 detected with this technique was considerably weaker than the 
reduction of co-localization with Rab7. We therefore confirmed the increased co-localization 
of GABAB receptors with Rab11 after blocking CaMKII by in situ PLA (145 ± 32%, of 
control; Fig. 2D). Thus, inhibition of CaMKII appears to prevent recruitment of GABAB 
receptors to the lysosomal degradation pathway. This observation suggests that basal CaMKII 
activity is involved in targeting GABAB receptors to lysosomes for degradation.  
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Fig 2. CaMKII triggers sorting of 
GABAB  receptors to lysosomes.  
A, Blocking CaMKII activity does not 
affect internalization of GABA B 
receptors. GABA B2  antibody-labelled cell 
surface receptors of living neurons were 
incubated for the indicated time intervals 
at 37°C to permit endocytosis. 
Subsequently, remaining cell surface 
GABA B2 -labeled receptors were 
quantified by immunofluorescence 
microscopy. The immunofluorescence 
signals of neurons at time 0 (not exposed 
to 37°C) were set to 100%. Data were 
fitted by nonlinear regression to one 
phase decay. The data represent the mean 
± SD of 35-46 neurons per time point 
from two independent experiments. 
B, C, Blocking CaMKII activity 
decreased the co-localization of GABA B 
receptors with Rab7 (marker for the 
lysosomal pathway) and increased the co-
localization with Rab11 (marker for 
recycling endosomes). Neurons were 
treated with KN93 and immunostained 
for GABA B2  (red) and Rab7 or Rab11 
(green). The yellow clusters in the 
merged image indicate the co-localization 
of GABA B2  with Rab7 or Rab11, 
respectively (left, representative images; 
scale bars: 5 μm). Right, quantification of 
co-localization. The data represent the 
mean ± SD of 30-60 neurons from three 
independent experiments; * p< 0.05, 
**** p< 0.0001, two-tailed unpaired t-
test. 
D, In-situ PLA confirmed the increased 
colocalization of GABA B receptors with 
Rab11 after blocking CaMKII. Neurons 
were treated or not with KN93 and 
subjected to in situ PLA using antibodies 
directed against GABA B1  and Rab11. 
Left, representative images (scale bar: 5 μm). Right, quantification of PLA signals (white dots in images). The 
PLA signals were normalized to the cell area. The control condition was set to 100%. The data represent the 
mean ± SD of 30 cells from two independent experiments. **** p< 0.0001; two-tailed unpaired t-test. 
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 CaMKIIβ  Promotes Lys-63-linked Ubiquitination of GABAB Receptors – The results so far 
support the hypothesis that CaMKIIβ  regulates lysosomal degradation of GABAB receptors. 
We had previously shown that lysosomal degradation of GABAB receptors depends on Lys-
63-linked ubiquitination of GABAB1 at multiple sites via the E3 ligase MIB2 (Zemoura et al., 
2016). It was therefore likely that CaMKIIβ  controls Lys-63-linked ubiquitination of GABAB 
receptors. 
 To test this hypothesis, we first analysed the effect of various ubiquitin mutants on the 
down-regulation of cell surface GABAB receptors induced by overexpression of CaMKIIβ . 
Overexpression of CaMKIIβ  in neurons reduced cell surface GABAB receptors to 43 ± 18% 
of control neurons transfected with EGFP (Fig. 3). Additional overexpression of wild type 
ubiquitin (Ub, 36 ± 25% of control), a ubiquitin mutant that permits only Lys-63-linked 
ubiquitination (Ub(K63), 35 ± 18% of control) as well as a mutant that prevents Lys-48-
linked ubiquitination (Ub(K48R), 39 ± 24% of control) did not affect CaMKIIβ-induced 
down-regulation of the receptors (43 ± 18% of control). However, overexpressing a ubiquitin 
mutant in which all lysine residues were mutated to arginine to entirely block 
polyubiquitination (Ub(KO), 109 ± 22% of control) as well as a ubiquitin mutant that 
specifically prevents Lys-63-linked ubiquitination (Ub(K63R), 124 ± 40% of control) 
completely prevented down-regulation of the receptors or even increased cell surface 
expression of the receptors (Fig. 3). These results indicate that down-regulation of GABAB 
receptors induced by overexpression of CaMKIIβ  is mediated by Lys-63-linked 
ubiquitination.  
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Fig 3. CaMKIIβ induced down-regulation of 
cell surface GABAB  receptors depends on Lys-
63-linked ubiquitination. 
Neurons were either transfected with EGFP 
(control), CaMKIIβ or CaMKIIβ plus ubiquitin 
(Ub) or one of its mutants (Ub(K63): only Lys-63 
linkages, Ub(K63R): no Lys-63 linkages, 
Ub(K48R): no Lys-48 linkages, Ub(KO): no 
polyubiquitin linkages only mono-
ubiquitination). Two days after transfection, 
neurons were stained for GABA B receptors using 
GABA B2  antibodies. Only interference with K63-
linked ubiquitination prevented CaMKIIβ-
mediated down-regulation of the receptors. 
Representative images of stained neuronal somata 
(scale bar, 5 μm). The scatter plot shows 
quantification of fluorescence intensities. The 
fluorescence signal of neurons transfected EGFP 
was set to 100%. The data represent the mean ± 
SD of 28-30 neurons from two independent 
experiments. *** p< 0.001; one way ANOVA, 
Dunnett’s Multiple Comparison test. 
  
 Next, we tested for direct CaMKIIβ-induced Lys-63-linked ubiquitination of GABAB 
receptors using in situ PLA and antibodies directed against GABAB1 and Lys-63-linked 
ubiquitin. Inhibition of CaMKII with KN93 significantly reduced basal Lys-63-linked 
ubiquitination of the receptor (69 ± 43% of control, Fig. 4A). In addition, overexpression of 
the functionally inactive CaMKIIβ  mutant CaMKIIβ(DN) in neurons considerably reduced 
Lys-63-linked ubiquitination of the receptors (46 ± 24%, Fig. 4B) as compared to neurons 
transfected with wild type CaMKIIβ . In contrast, overexpression of the functionally inactive 
mutant of CaMKIIα (CaMKIIα(DΝ)) had no effect on the level of Lys-63-linked 
ubiquitinated GABAB receptors as compared to wild type CaMKIIα. Finally, neither 
overexpression of CaMKIIα(DN) nor CaMKIIβ(DN) affected Lys-48 linked ubiquitination of 
the receptors, which is required for their proteasomal degradation (Fig. 4C). These results 
indicate that CaMKIIβ  is involved in the regulation of Lys-63-linked ubiquitination of 
GABAB receptors. 
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Fig 4. CaMKII regulates K63-linked 
ubiquitination of GABAB  receptors. 
A, Inhibition of CaMKII activity 
reduced K63-linked ubiquitination of 
GABA B receptors. Neurons were 
incubated for 7.5 minutes in the 
absence (control) or presence of KN93 
and analysed for K63-linked 
ubiquitination of GABA B receptor by 
in situ PLA using antibodies directed 
against GABA B1  and K63-linked 
ubiquitin (white dots in representative 
images (scale bar: 5 μm). Right, 
quantification of in situ PLA signals. 
The data represent the mean ± SD of 
33 (control) and 30 (KN93) neurons 
from two independent experiments. ** 
p< 0.01, two-tailed unpaired t-test. 
B, C, CaMKIIβ promotes Ly-63-linked 
ubiquitination of GABA B receptors. 
Neurons were transfected with either 
CaMKIIα or CaMKIIβ or their 
functionally inactive mutants 
CaMKIIα(DN) or CaMKIIβ(DN). 
After two days, GABA B receptors 
were tested for Lys-63-linked (B) or 
Lys-48-linked (C) ubiquitination by in 
situ PLA using antibodies directed 
against GABA B1  and Lys-63 or Lys-48 
ubiquitin. Left, representative images 
depicting PLA signals (white dots, 
scale bars: 5 μm). Right, quantification 
of PLA signals. The data represent the 
mean ± SD of 17-21 neurons from two independent experiments. **** p< 0.0001; two-tailed unpaired t-test. 
  
 We recently identified in GABAB1 several lysine residues (Lys-697/698, Lys-892 and Lys-
960) that are substrates for Lys-63-linked ubiquitination and important for targeting the 
receptors to lysosomal degradation (Zemoura et al., 2016). To further substantiate the finding 
that CaMKII regulates lysosomal degradation of GABAB receptors by promoting Lys-63-
linked ubiquitination of GABAB1, we tested whether blocking CaMKII affects cell surface 
expression of three GABAB1a(K->R) mutants in which Lys-697/698, Lys-892 and Lys-960 
were mutated to arginine (GABAB1a(K697/698R), GABAB1a(K892R) and 
GABAB1a(K960R)). In contrast to receptors containing wild type GABAB1, which displayed 
increased cell surface expression upon treatment with KN63 (GABAB1: 164 ± 149%, 
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GABAB2: 142 ± 91% of control; Fig. 5), the expression level of receptors containing any of 
the three GABAB1a(K->R) mutants remained unaffected by inhibition of CaMKII 
(GABAB1a(K697/698R), control: 552 ± 426%, KN93: 490 ± 456%; GABAB1a(K892R), 
control: 421 ± 284%, KN93: 370 ± 272%; GABAB1a (K960R), control: 273 ± 256%, KN93: 
281 ± 270% of control wild type GABAB1. GABAB2 co-expressed with GABAB1a 
(K697/698R), control: 160 ± 115%, KN93: 140 ± 117%; GABAB2 co-expressed with 
GABAB1a(K892R), control: 184 ± 106%, KN93: 163 ± 88%; GABAB2 co-expressed with 
GABAB1a(K960R), control: 147 ± 84%, KN93: 145 ± 78% of wild type control; Fig. 5). In 
conclusion, these findings suggest that CaMKII is involved in K63-linked ubiquitination of 
GABAB1 at K697/698, K892 as well as K960. 
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Fig 5. Blocking CaMKII did not affect 
the expression levels of GABAB1a (K-
>R) mutants. 
 Neurons were transfected with HA-
tagged wild type GABA B1a or HA-tagged 
GABA B1a (K->R) mutants along with 
GABA B2  and tested for cell surface 
expression of GABA B1  and GABA B2  
after treating the neurons with 10 μM 
KN93 for 7.5 minutes. Left, 
representative images of untreated 
neurons (control, left panels) and of 
neurons treated with KN93 (right panels, 
scale bar: 5 μm). The corresponding 
graphs show the quantification of 
fluorescence signals. The fluorescence 
intensity of neurons transfected with wild 
type GABA B1  from untreated neurons 
(control) was set to 100%. The data 
represent the mean ± SD of 45-60 
neurons per experimental condition 
derived from three independent 
experiments. Please note that the 
considerably lower increase in GABA B2  
cell surface expression as compared with 
mutant GABA B1  was due to the fact that 
in case of GABA B1  only transfected 
subunits were detected (HA-tagged) but 
in the case of GABA B2  transfected as 
well as endogenously expressed subunits 
were detected. *** p< 0.001, two-tailed 
unpaired t-test. 
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 CaMKII regulates cell surface receptors by promoting MIB2-mediated Lys-63-linked 
ubiquitination via phosphorylation of GABAB1 at Ser-867 – CaMKII phosphorylates GABAB1 
at Ser-867 (Guetg et al., 2010). To prove that direct phosphorylation of Ser-867 in GABAB1 is 
involved in the regulation of GABAB receptor cell surface expression, we silenced this 
phosphorylation site by mutating it to alanine (GABAB1(S867A)) or rendered the site 
permanently active by mutating it to aspartate (GABAB1(S867D)). First, we verified that 
CaMKIIβ  indeed phosphorylates GABAB1 at Ser-867 by in situ PLA using antibodies 
directed against GABAB1 and phosphoserine. Upon expression in HEK 293 cells, wild type 
GABAB receptors displayed a basal level of serine phosphorylation, which was more than 
three-fold enhanced by co-expression with CaMKIIβ  (PLA signal GABAB1: 98 ± 5, GABAB1 
+ CaMKIIβ: 358 ± 14; Fig. 6A). In contrast, GABAB receptors in which Ser-867 of GABAB1 
was inactivated by mutation to alanine, only basal level of serine phosphorylation was 
detected in the presence of CaMKIIβ  (PLA signal GABAB1(S867A) + CaMKIIβ: 108 ± 6 
compared to GABAB1: 98 ± 5, Fig. 6A). These results confirm that CaMKIIβ  specifically 
phosphorylates GABAB1 at Ser-867. 
 Next, we tested the effect of inactivating or permanently mimicking phosphorylation of 
GABAB1 Ser-867 on cell surface expression of the receptors by expressing GABAB1(S867A) 
or GABAB1(S867D) in cortical neurons. Inactivation of GABAB1 Ser-867 considerably 
increased cell surface expression of receptors containing GABAB1(S867A) (271 ± 119% of 
control, Fig. 6B) upon transfection in neurons, whereas receptors containing the 
phosphomimetic GABAB1(S867D) mutant were expressed at reduced levels (50 ± 22% of 
control, Fig. 6B). In line with this finding, receptors containing the CaMKII phosphorylation 
deficient GABAB1(S867A) mutant exhibited reduced K63-linked ubiquitination (47 ± 32% of 
control, Fig. 6C), while receptors containing the phosphomimetic GABAB1(S867D) mutant 
showed a considerably higher level of Lys-63-linked ubiquitination (226 ± 76% of control, 
Fig. 6C). These findings suggest that CaMKII promotes Lys-63-linked ubiquitination of 
GABAB receptors via phosphorylation of serine 867 in GABAB1.  
15 
 
 
Fig 6. Phosphorylation of GABAB1  Ser-867 controls cell surface expression and Lys-63-linked 
ubiquitination of GABAB  receptors. 
A, CaMKIIβ phosphorylates GABA B1  at Ser-867. HEK293 cells were transfected either with GABA B1 /GABA B2  
with or without CaMKIIβ or with GABA B1 (S867A)/GABA B2  and CaMKIIβ. Two days after transfection, the 
cells were tested for serine phosphorylation by in situ PLA using antibodies directed against GABA B1  and 
phosphoserine. Left, representative images (scale bar: 10 µm, wt: wild type). Right, quantification of PLA 
signals (white dots in images). The PLA signals were normalized to the cell area as well as to the expression 
level of GABA B1 . The data represent the mean ± SD of 50 cells from two independent experiments. ns p> 0.05, 
*** p< 0.001; one way ANOVA, Dunnett’s Multiple Comparison test.  
B, C, Inactivation or constitutively mimicking phosphorylation of GABA B1  Ser-867 affects cell surface 
expression (B) as well as Lys-63-linked ubiquitination (C) of the receptors. Neurons were transfected with wild 
type HA-tagged GABA B1a (control), with the phosphorylation deficient HA-tagged GABA B1a(S867A) mutant or 
with the phosphomimetic HA-tagged GABA B1a(S867D) mutant along with GABA B2  and tested for cell surface 
expression using HA antibodies (B) as well as for Lys63-linked ubiquitination by in situ PLA with HA and 
GABA B1  antibodies (C). Left, representative images (scale bars: 5 μm). Right, quantification of fluorescence 
intensities (B) and PLA signals (C). The data represent the mean ± SD of 23-27 (B) and 18-20 neurons (C) from 
two independent experiments. * p< 0.05, *** p< 0.001; one way ANOVA, Dunnett’s Multiple Comparison test. 
 We previously showed that Lys-63-linked ubiquitination of GABAB1 is mediated by the 
ubiquitin E3 ligase MIB2 (Zemoura et al., 2016). We therefore tested for the involvement of 
MIB2 in CaMKIIβ-induced down-regulation of GABAB receptors. Overexpression in 
neurons of MIB2 or CaMKIIβ  reduced cell surface expression of GABAB receptors to a 
similar extent (MIB2: 40 ± 16%, CaMKIIβ: 45 ± 17% of EGFP transfected control neurons; 
Fig. 7A). Co-transfection of MIB2 and CaMKIIβ  in neurons did not further increase down-
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regulation of the receptors (43 ± 14% of EGFP transfected control neurons; Fig. 7A), 
indicating that both enzymes affect GABAB receptors via the same pathway. In line with this 
observation, MIB2 was unable to downregulate cell surface GABAB receptors when the non-
functional CaMKIIβ  mutant CaMKIIβ(DN) was simultaneously overexpressed with MIB2 
(CaMKIIβ(DN): 195 ± 42%, CaMKIIβ(DN) + MIB2: 200 ± 43% of EGFP transfected control 
neurons, Fig. 7A).  
 Next, we tested whether MIB2-mediated down-regulation of GABAB receptors depends on 
phosphorylation of GABAB1 Ser-867. Co-transfection of GABAB1a,2  and MIB2 in neurons 
strongly reduced cell surface expression of receptors containing transfected GABAB1a (28 ± 
11% of control, Fig. 7B). However, MIB2 failed to affect expression of the elevated or 
reduced cell surface expression levels of receptors containing GABAB1a(S867A) or 
GABAB1a(S867D) (S867A: 204 ± 39%, S867A + MIB2: 211 ± 38%, S867D: 23 ± 8%, 
S867D + MIB2: 24 ± 9% of control, Fig. 7B). Together, these results indicate that 
phosphorylation of GABAB1 at Ser-867 by CaMKIIβ  is required for MIB2-mediated 
downregulation of GABAB receptors. 
 Finally, we tested the hypothesis that CaMKII-mediated phosphorylation of GABAB1 
might affect the interaction of MIB2 with GABAB receptors. Upon transfection in HEK 293 
cells, MIB2 displayed considerably lower interaction with receptors containing the phospho-
deficient mutant GABAB1a (S867A) (25 ± 15% of control, Fig. 7C) and a higher level of 
interaction with receptors containing the phospho-mimetic mutant GABAB1a(S867D) (126 ± 
44% of control, Fig. 7C) than wild type receptors. This result indicates that phosphorylation 
of GABAB1 at Ser-867 promotes the interaction of GABAB receptors with MIB2. 
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Fig 7. The ubiquitin E3 ligase MIB2 
is involved in CaMKIIβ-mediated 
regulation of cell surface GABAB  
receptors. 
A, Overexpression of MIB2 in 
addition to CaMKII does not enhance 
down-regulation of cell surface 
GABA B receptors. Neurons were 
transfected with the indicated plasmid 
and tested for cell surface expression 
of GABA B receptors using GABA B2  
antibodies two days after transfection. 
Co-expression of MIB2 did not further 
enhance downregulation of cell 
surface receptors, indicating the 
involvement in the same pathway. 
Upper panels show representative 
images (scale bars: 5 μm). The graphs 
depict quantification of the 
fluorescence signals. The data 
represent the mean ± SD of 30 
neurons per condition derived from 
two independent experiments. ns p> 
0.05, *** p< 0.001; one way ANOVA, 
Bonferroni’s Multiple Comparison 
test. 
B, MIB2-induced down-regulation of 
cell surface receptors depends on 
phosphorylation of GABA B1  Ser-867. 
Neurons were transfected with wild 
type HA-tagged GABA B1a (control), 
with the phosphorylation deficient 
HA-tagged GABA B1a(S867A) mutant 
or with the phosphomimetic HA-
tagged GABA B1a(S867D) mutant 
along with GABA B2  and with or 
without MIB2. Two days after 
transfection, neurons were tested for 
cell surface expression of tagged 
GABA B1  using HA antibodies. Upper 
panels show representative images 
(scale bars: 5 μm). The graph depicts 
quantification of the fluorescence 
signals. The data represent the mean ± 
SD of 30 neurons per condition 
derived from two independent 
experiments. ns p> 0.05, *** p< 
0.001; one way ANOVA, 
Bonferroni’s Multiple Comparison test. 
C, GABA B1  phospho-mutants display altered MIB2 interaction. HEK 293 cells were transfected with wild type 
GABA B1 , GABA B1 (S867A) or GABA B1 (S867D) together with GABA B2  and MIB2. Two days after 
transfection, cells were analysed for interaction of GABA B receptors with MIB2 by in situ PLA using antibodies 
directed against GABA B1  and MIB2. Upper panels show representative images (scale bar: 10 μm). The graph 
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depicts quantification of the PLA signals. The data represent the mean ± SD of x neurons per condition derived 
from two independent experiments. *** p< 0.001; one way ANOVA, Dunnett’s Multiple Comparison test. 
 
 Sustained Activation of Glutamate Receptors Increases Lys-63-linked Ubiquitination of 
GABAB Receptors via phosphorylation of GABAB1 Ser-867 – Glutamate-induced down-
regulation of GABAB receptors via lysosomal degradation depends on CaMKII-mediated 
phosphorylation of GABAB1 Ser-867 (Guetg et al., 2010) as well as on Lys-63-linked 
ubiquitination of GABAB1 at Lys-697/698, Lys-892 and Lys-960 (Zemoura et al., 2016). To 
investigate whether glutamate-induced K63-linked ubiquitination of GABAB receptors 
depends on phosphorylation of Ser-867, we expressed wild type GABAB1, or the two mutants 
GABAB1(S867A) and GABAB1(S867D) in cortical neurons and exposed them for 60 min to 
glutamate. Under this condition, cell surface wildtype GABAB receptors were down-regulated 
to 30 ± 20% as compared to untreated controls (Fig. 8A). However, receptors containing the 
phospho-deficient mutant GABAB1(S867A) showed enhanced cell surface expression under 
control conditions (240 ± 99% of wild type controls) and were not affected by glutamate (240 
± 94% of wild type controls, Fig. 8A). In contrast, receptors containing the phospho-mimetic 
mutant GABAB1(S867D) displayed strongly reduced expression under control conditions (45 
± 24% of wild type controls, Fig. 8A) and remained unaffected after glutamate treatment (44 
± 23% of wild type controls, Fig. 8A). A complementary pattern was observed for Lys-63-
linked ubiquitination of the respective receptors as tested by in situ PLA. Treatment of 
cultured neurons with glutamate strongly increased K63-linked ubiquitination of wildtype 
GABAB receptors (control: 100 ± 60%, glutamate 247 ± 84%, Fig. 8B), whereas receptors 
containing the phospho-deficient mutant GABAB1(S867A) displayed only marginal Lys-63-
linked ubiquitination under both conditions (control: 10 ± 13%, glutamate 11 ± 13, Fig. 8B) 
and the phospho-mimetic mutant GABAB1(S867D) exhibited strongly enhanced Lys-63-
linked ubiquitination (control: 175 ± 126, glutamate 181 ± 121, Fig. 8B). 
 These findings suggest that sustained activation of glutamate receptors induces GABAB1-
Ser-867 phosphorylation-mediated K63-linked ubiquitination of GABAB receptors, 
promoting their lysosomal degradation. 
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Fig 8. Glutamate-induced down-regulation of GABAB  receptors is mediated by GABAB1  Ser-867 
phosphorylation induced Lys-63-linked ubiquitination. 
A, B, Neurons transfected with wild type HA-tagged GABA B1a, with the phosphorylation deficient HA-tagged 
GABA B1a(S867A) mutant or with the phospho-mimetic HA-tagged GABA B1a(S867D) mutant along with 
GABA B2  were incubated for 60 min in the absence (control) or presence of 50 μM glutamate. Neurons were 
analysed for cell surface expression of transfected GABA B1  using HA antibodies (A) or analysed for Lys-63-
linked ubiquitination by in situ PLA using HA and GABA B1  antibodies (B). Upper panels show representative 
images (scale bars: 5 μm). The graphs depict quantification of the fluorescence signals (A) and in situ PLA 
signals (B). The data represent the mean ± SD of 28-30 (A) and 28-36 (B) neurons per condition derived from 
three independent experiments. ns p> 0.05, * p< 0.05, ** p< 0.01, *** p< 0.001, **** p< 0.0001; one way 
ANOVA, Bonferroni’s Multiple Comparison test.  
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Discussion  
 The expression of GABAB receptors available for signal transduction at the cell surface 
critically depends on their rates of degradation. The two main cellular degradation systems - 
proteasomes and lysosomes - control the abundance of GABAB receptors in distinct cellular 
compartments in response to the activity state of the neuron (Zemoura et al., 2016, 2013; 
Zemoura and Benke, 2014). In the ER, the amount of newly synthetized GABAB receptors 
destined for trafficking to the plasma membrane is regulated by proteasomal degradation via 
the ERAD machinery (Zemoura et al., 2013), whereas cell surface GABAB receptors are 
degraded in lysosomes (Grampp et al., 2008, 2007; Hannan et al., 2011; Kantamneni et al., 
2008; Vargas et al., 2008). Both degradation pathways require ubiquitination of the receptor 
as targeting signals. Lys-48-linked ubiquitination of GABAB2 at Lys-767/771 tags GABAB 
receptors for proteasomal degradation  (Zemoura et al., 2013) and Lys-63-linked 
ubiquitination of GABAB1 at several sites sorts the receptors to lysosomes (Zemoura et al., 
2016). The mechanisms regulating lysosomal degradation of GABAB receptors in response to 
changes in the physiological state of the neuron were unclear. 
 Under normal physiological conditions, cell surface GABAB receptors constitutively 
internalize to early endosomes and recycle to the plasma membrane or are sorted to lysosomes 
for degradation (Grampp et al., 2008, 2007; Pooler et al., 2009; Vargas et al., 2008; Wilkins et 
al., 2008). Sorting the receptors to recycling or degradation must be precisely regulated in 
order to provide the required number of cell surface receptors for signal transduction under a 
given physiological condition. However, after prolonged activation of glutamate receptors 
GABAB receptors are rapidly down-regulated by shifting the recycling/degradation balance 
towards lysosomal degradation (Kantamneni et al., 2014; Maier et al., 2010; Terunuma et al., 
2010a,b). This down-regulation of GABAB receptors critically depends on CaMKII-mediated 
phosphorylation of GABAB1 on Ser-867 (Guetg et al., 2010) as well as on Lys-63-linked 
ubiquitination of GABAB1 mediated by the E3 ligase MIB2 (Zemoura et al., 2016). As the 
level of CaMKII activity is regulated by the intracellular Ca2+ concentration, it is in an ideal 
position to link the increased neuronal activity after prolonged activation of glutamate 
receptors to lysosomal degradation of GABAB receptors at least under pathological 
conditions. We, therefore, hypothesized that CaMKII regulates lysosomal degradation also 
under physiological conditions. Indeed, we found that pharmacologically blocking CaMKII 
significantly increased cell surface expression of GABAB receptors. This increase was 
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accompanied by a reduced colocalization of the receptors with the late endosomal marker 
Rab7, indicating that inhibition of CaMKII prevented sorting of GABAB receptors to 
lysosomes. Our data also imply that a considerable fraction of GABAB receptors is 
constitutively degraded under basal conditions since blocking CaMKII activity for only 7.5 
min was sufficient to induce a significant increase (~150%) of cell surface GABAB receptors. 
 CaMKII is a large protein complex constituted from 12 catalytically active subunits of 
different isoforms (CaMKIIα-δ) (Hell, 2014). In brain, CaMKIIα and CaMKIIβ  are the 
predominant subunits and in forebrain neurons the CaMKII holoenzyme largely consists of 9 
α subunits and 3 β subunits (Brocke et al., 1999; Miller and Kennedy, 1985). Interestingly, 
we found that overexpression of CaMKIIβ , but not CaMKIIα, increased the level of GABAB 
receptor/CaMKII interaction in an activity dependent manner (inhibition of CaMKII activity 
prevented the increase in interaction), resulting in decreased cell surface receptor expression. 
Consistent with this observation, overexpressing its functionally inactive mutant 
CaMKIIβ(DN), which was expected to inhibit CaMKIIβ  activity and thus lysosomal 
degradation of the receptors, increased cell surface expression of GABAB receptors. As 
intracellular Ca2+ concentrations under basal conditions are low, this finding fits well to the 
observation that CaMKIIβ  exhibit a 9-fold higher affinity to Ca2+/calmodulin than CaMKIIα 
(Brocke et al., 1999). Thus, our data suggest that under normal physiological conditions basal 
CaMKIIβ  activity determines the level of lysosomal degradation of GABAB receptors. 
 Phosphorylation often regulates ubiquitination of proteins thereby promoting their 
degradation (Lin et al., 2002; Schroeder et al., 2012; Su et al., 2013). Several lines of 
evidence indicate that regulation of cell surface GABAB receptors by CaMKIIβ  is conveyed 
by MIB2-mediated Lys-63-linked ubiquitination of GABAB1. First, overexpression in 
neurons of ubiquitin mutants unable to form Lys-63-linkages prevented down-regulation of 
GABAB receptors induced by overexpression of CaMKIIβ , while a mutant that only can form 
Lys-63-linkages, but not any other kind of linkages, had no effect. Second, blocking CaMKII 
activity pharmacologically or by overexpression of the functionally inactive mutant 
CaMKIIβ(DN) reduced Lys-63-linked ubiquitination of GABAB receptors. Third, the cell 
surface expression of three GABAB1a(K->R) mutants with inactivated Lys-63-linked 
ubiquitination sites, which are indispensable for lysosomal targeting of the receptors 
(Zemoura et al., 2016), remained unaffected by CaMKII inhibition. Fourth, overexpression of 
the E3 ligase MIB2, which down-regulates GABAB receptors via lysosomal degradation 
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(Zemoura et al., 2016), neither enhanced CaMKIIβ-mediated downregulation of cell surface 
receptors nor affected the expression of a GABAB1 mutant with inactivated CaMKII 
phosphorylation site (GABAB1(S867A)). Finally, our experiments with the CaMKII 
phosphorylation-deficient and phosphomimetic GABAB1(S867) mutants indicate that direct 
phosphorylation of GABAB1 Ser-867 promotes Lys-63-linked ubiquitination and thereby 
degradation of GABAB receptors. Under normal physiological as well as conditions of over-
excitation via prolonged activation of glutamate receptors the phospho-deficient mutant 
GABAB1(S867A) displayed only marginal Lys-63-linked ubiquitination and increased cell 
surface expression whereas the phosphomimetic mutant GABAB1(S867D) exhibited strongly 
increased Lys-63-linked ubiquitination and reduced cell surface expression.  
 The precise mechanism by which CaMKIIβ  promotes Lys63-linked ubiquitination of 
GABAB1 remains unresolved. Phosphorylation of GABAB1(S867) might be the signal that 
targets the receptors to an endosomal compartment where they are Lys-63-linked 
ubiquitinated by MIB2. Alternatively, phosphorylation of GABAB1(S867) might induce a 
conformational change in the receptor that uncovers the MIB2 interaction site or exposes the 
lysine residues for ubiquitination. We favour the later hypothesis, which is supported by our 
finding that MIB2 displayed increased interaction with the phospho-mimetic mutant 
GABAB1(S867D) and reduced interaction with the phospho-deficient mutant 
GABAB1(S867A). However, further experimentation is required to reveal the mechanism as 
to how CaMKIIβ  promotes Lys-63-linked ubiquitination of GABAB1. 
 In conclusion, our data indicate that phosphorylation of GABAB1 at Ser-867 by CaMKIIβ  
induces MIB2-mediated K63-linked ubiquitination of GABAB1 at multiple sites, which sorts 
GABAB receptors to lysosomes for degradation. This mechanism is expected to fine-tune cell 
surface expression of GABAB receptors under physiological conditions and to considerably 
affect receptor expression in diseases associated with disturbed Ca2+ homeostasis. 
Experimental Procedures 
 Antibodies – mouse anti-HA (clone HA-7, 1:1000 for immuno-fluorescence, 1:500 for in 
situ PLA, Sigma-Aldrich catalogue no. H9658, lot no. 024M4773), rabbit CaMKII (1: 100 
for PLA; Abcam catalogue no. ab52476, lot no. GR181543-20), rabbit GABAB1b directed 
against the N-terminus of GABAB1b (affinity-purified, 1:200 for immunofluorescence, 
custom made by GenScript) (Benke et al., 1999), rabbit GABAB2 directed against the N-
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terminus of GABAB2 (affinity-purified, 1:500 for immunofluorescence; custom made by 
GenScript) (Benke et al., 2002), guinea pig GABAB2 (1:500 for immunofluorescence; 
Millipore catalogue no. AB2255, lot no. 2484228), mouse GABAB1 (1:50 for PLA; 
NeuroMab, clone N93A/49, catalogue no. 75-183), rabbit ubiquitin K48-specific (clone 
Apu2, 1:50 for in situ PLA; Millipore, catalogue no. 05-1307, lot no. 2385989), rabbit 
ubiquitin K63-specific (clone Apu3, 1:50 for in situ PLA; Millipore, catalogue no. 05-1308, 
lot no. 2575910), rabbit MIB2 (1: 1000 for immunofluorescence, 1:250 for PLA; 
MyBioSource, catalogue no. MBS2014413, lot no. A20160407515), mouse phosphoserine 
(PSR-45, 1:150 for in situ PLA; Sigma Aldrich, catalogue no. P5747, lot no. 014M4791V), 
goat Rab7 (1:250 for immunofluorescence; Santa Cruz Biotechnology, catalogue no. sc-
11303, lot no. BO911), mouse Rab11 (clone 47, 1:40 for immunofluorescence and in situ 
PLA; Millipore, catalogue no. 05-853, lot no. JBC1868959). Secondary antibodies were 
labelled with either Alexa Fluor 488 (1:1000, Invitrogen), Cy-3 (1:500, Jackson 
ImmunoResearch Laboratories) or Cy-5 (1:300, Jackson ImmunoResearch Laboratories). 
 Drugs – The following chemicals were used for this study: glutamate (50 μM, Sigma-
Aldrich) and KN93 (10 μM, Tocris Bioscience). 
 Plasmids – HA-tagged GABAB1a (Kaupmann et al., 1997); GABAB2 (Kaupmann et al., 
1998); HA-tagged GABAB1a(K689/699R), GABAB1a(K893R) and GABAB1a(K961R) 
(Zemoura et al., 2016); GFP-tagged CaMKIIα (Addgene plasmid 21226) (Shen et al., 1998) 
and its functionally inactive mutant GFP-tagged CaMKIIα(K42M) (here designated 
CaMKIIα(DN)) (kindly provided by U. Bayer, University of Colorado Denver-AMC); GFP-
tagged CaMKIIβ (Addgene plasmid 21227) (Shen et al., 1998) and its functionally inactive 
mutant EGFP-tagged CaMKIIβ(K43R) (here designated CaMKIIβ(DN)) (Addgene plasmid 
21225) (Shen and Meyer, 1999); HA-tagged ubiquitin (Addgene plasmid 17608), HA-tagged 
ubiquitin (KO) (Addgene plasmid 17603), HA-tagged ubiquitin (K63) (Addgene plasmid 
17606) and HA-tagged ubiquitin (K48R) (Addgene plasmid 17604) (Lim et al., 2005); HA-
tagged ubiquitin (K63R) was kindly provided by L.-Y. Liu-Chen, Temple University, 
Philadelphia, USA. 
 Mutation of GABAB1a  – Serine 867 in GABAB1a was mutated either to alanine or to 
aspartate by GenScript. 
 Culture and transfection of cortical neurons – Primary cultures of cerebral cortex were 
prepared from 18 day old embryos of Wistar rats as described previously (Grampp et al., 
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2008). Neurons were used after 11 to 15 days in culture. Plasmid DNA was transfected into 
neurons co-cultured with glia cells by magnetofection using Lipofectamine 2000 (Invitrogen) 
and CombiMag (OZ Biosciences) exactly as specified in  (Buerli et al., 2007). In our hands, 
this method reliably yields 50-100 transfected neurons, when transfection was performed with 
11-13 day old cultures. 
 Culture and transfection of HEK 293 cells – HEK (human embryonic kidney) 293 cells 
were cultured in Dulbecco’s modified Eagle’s medium (DMEM, Gibco Life Technologies) 
containing 10% foetal bovine serum (Gibco Life Technologies) and penicillin/streptomycin 
(Gibco Life Technologies). Plasmids were introduced into HEK 293 cells using the 
polyethylenimine method according to the jet-PEI protocol (Polyplus Transfection). 
 Immunocytochemistry and confocal laser scanning microscopy – Immunofluorescence 
staining was done as described previously (13,22). For detection of total GABAB receptors, 
neurons were fixed for 15-20 min at room temperature with 4% paraformaldehyde followed 
by permeabilization with 0.2% Triton X-100 and immunostaining. For analysis of cell surface 
GABAB receptors, living neurons were incubated with antibodies recognizing the 
extracellularly located N-terminal domain of GABAB1 or GABAB2 for one hour at 4°C. After 
washing the neurons were incubated with fluorophore-labelled secondary antibodies for one 
hour at 4°C and fixed with 4% paraformaldehyde. 
 Images of stained neurons were recorded by laser scanning confocal microscopy (LSM 
510 Meta, LSM 700 or LSM 710; Zeiss). Five to eight optical sections spaced by 0.3 µm was 
taken with either a 40x, 63x or 100x plan-fluor oil differential interference contrast objective 
(1.45 NA, Zeiss) at a resolution of 1024 x 1024 pixels. Total and cell surface fluorescence 
signals were quantified using the ImageJ software as described previously (Maier et al., 
2014). To determine cell surface expression of GABAB receptors, all optical sections were 
merged into one image. Then the inner as well outer border of somatic staining was carefully 
outlined and the mean intensity values were measured. Values for cell surface signals were 
obtained by subtracting the values of the inner border from those of the outer border. For 
analysis of total GABAB receptor expression, the somata of neurons were carefully outlined 
and the mean intensity values were measured. For each image, background staining was 
determined in an area containing no specific signal and subtracted from the mean intensity 
values. All values were normalized to the analysed cell area. 
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Proteins over-expressed in neurons were either tagged with GFP or the HA epitope, which 
were used to identify transfected neurons and to judge the protein expression level. In case of 
overexpression studies, transfected neurons with comparable expression of the protein of 
interested were included into the analysis.  
 Quantification of co-localization of GABAB receptors with Rab7 and Rab11 was done 
with the Mac Biophotonics Image J software (JACoP plugin, “Co-localization Threshold”). 
This method of quantitative co-localization analysis of fluorescence signals is based on an 
algorithm that automatically set the thresholds for co-localization using spatial statistics and 
thus excludes bias by the experimenter (Costes et al., 2004). 
 In situ proximity ligation assay (in situ PLA) – In situ PLA is an antibody based 
technology for the detection of protein-protein interactions and posttranslational 
modifications of proteins (Leuchowius et al., 2010; Söderberg et al., 2006). We applied in situ 
PLA for the analysis of GABAB receptor ubiquitination using mouse GABAB1 or mouse HA 
antibodies (for transfected HA-tagged GABAB1) together with rabbit antibodies specifically 
detecting K48-linked or K63-linked ubiquitin. In situ PLA was performed using Duolink PLA 
probes and detection reagents (Sigma-Aldrich) according to the manufacturer’s instructions as 
described previously (Maier et al., 2014). Quantification was done by counting individual in 
situ PLA spots using the Image J software. The optical sections of each image stack were 
merged into one image and the number of maxima was determined after setting an appropriate 
noise tolerance (noise tolerance was kept constant for all images of an experiment). The 
number of spots was normalized to the area analysed and to the expression level of GABAB 
receptors. 
 Internalization assay – Neurons were placed on ice and cell surface GABAB receptors 
were labelled with GABAB2 antibodies for one hour at 4°C. After extensive washes, neurons 
were incubated in 37°C warm medium for exactly 1, 2, 3, 5 or 10 min to permit receptor 
endocytosis. Endocytosis was terminated by replacing the medium with ice-cold buffer. After 
incubation with secondary antibody for one hour at 4°C, the neurons were fixed with 4% PFA 
and remaining cell surface GABAB receptors were determined by laser scanning confocal 
microscopy. 
 Statistics – The statistical analyses were done with GraphPad Prism 5. The tests used and p 
values are given in the figure legends. Differences were considered statistically significant 
when p < 0.05. 
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Fig 2. CaMKII triggers sorting of 
GABAB receptors to lysosomes.
A, Blocking CaMKII activity does not 
affect internalization of GABA B
receptors. GABA B2 antibody-labelled cell 
surface receptors of living neurons were 
incubated for the indicated time intervals 
at 37°C to permit endocytosis. 
Subsequently, remaining cell surface 
GABA B2 -labeled receptors were 
quantified by immunofluorescence 
microscopy. The immunofluorescence 
signals of neurons at time 0 (not exposed 
to 37°C) were set to 100%. Data were 
fitted by nonlinear regression to one 
phase decay. The data represent the mean 
± SD of 35-46 neurons per time point 
from two independent experiments. 
B, C, Blocking CaMKII activity 
decreased the co-localization of GABA B 
receptors with Rab7 (marker for the 
lysosomal pathway) and increased the co-
localization with Rab11 (marker for 
recycling endosomes). Neurons were 
treated with KN93 and immunostained 
for GABA B2 (red) and Rab7 or Rab11 
(green). The yellow clusters in the 
merged image indicate the co-localization 
of GABA B2 with Rab7 or Rab11, 
respectively (left, representative images; 
scale bars: 5 μm). Right, quantification of 
co-localization. The data represent the 
mean ± SD of 30-60 neurons from three 
independent experiments; * p< 0.05, 
**** p< 0.0001, two-tailed unpaired t-
test. 
D, In-situ PLA confirmed the increased 
colocalization of GABA B receptors with 
Rab11 after blocking CaMKII. Neurons 
were treated or not with KN93 and 
subjected to in situ PLA using antibodies 
directed against GABA B1  and Rab11. 
Left, representative images (scale bar: 5 μm). Right, quantification of PLA signals (white dots in images). The 
PLA signals were normalized to the cell area. The control condition was set to 100%. The data represent the 
mean ± SD of 30 cells from two independent experiments. **** p< 0.0001; two-tailed unpaired t-test. 
  
10
 
Fig 3. CaMKIIβ induced down-regulation of 
cell surface GABAB receptors depends on Lys-
63-linked ubiquitination. 
Neurons were either transfected with EGFP 
(control), CaMKIIβ or CaMKIIβ plus ubiquitin 
(Ub) or one of its mutants (Ub(K63): only Lys-63 
linkages, Ub(K63R): no Lys-63 linkages, 
Ub(K48R): no Lys-48 linkages, Ub(KO): no 
polyubiquitin linkages only mono-
ubiquitination). Two days after transfection, 
neurons were stained for GABA B receptors using 
GABA B2 antibodies. Only interference with K63-
linked ubiquitination prevented CaMKIIβ-
mediated down-regulation of the receptors. 
Representative images of stained neuronal somata 
(scale bar, 5 μm). The scatter plot shows 
quantification of fluorescence intensities. The 
fluorescence signal of neurons transfected EGFP 
was set to 100%. The data represent the mean ± 
SD of 28-30 neurons from two independent 
experiments. *** p< 0.001; one way ANOVA, 
Dunnett’s Multiple Comparison test. 
  
 Next, we tested for direct CaMKIIβ-induced Lys-63-linked ubiquitination of GABAB 
receptors using in situ PLA and antibodies directed against GABAB1 and Lys-63-linked 
ubiquitin. Inhibition of CaMKII with KN93 significantly reduced basal Lys-63-linked 
ubiquitination of the receptor (69 ± 43% of control, Fig. 4A). In addition, overexpression of 
the functionally inactive CaMKIIβ  mutant CaMKIIβ(DN) in neurons considerably reduced 
Lys-63-linked ubiquitination of the receptors (46 ± 24%, Fig. 4B) as compared to neurons 
transfected with wild type CaMKIIβ . In contrast, overexpression of the functionally inactive 
mutant of CaMKIIα (CaMKIIα(DΝ)) had no effect on the level of Lys-63-linked 
ubiquitinated GABAB receptors as compared to wild type CaMKIIα. Finally, neither 
overexpression of CaMKIIα(DN) nor CaMKIIβ(DN) affected Lys-48 linked ubiquitination of 
the receptors, which is required for their proteasomal degradation (Fig. 4C). These results 
indicate that CaMKIIβ  is involved in the regulation of Lys-63-linked ubiquitination of 
GABAB receptors. 
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Fig 4. CaMKII regulates K63-linked 
ubiquitination of GABAB  receptors. 
A, Inhibition of CaMKII activity 
reduced K63-linked ubiquitination of 
GABA B receptors. Neurons were 
incubated for 7.5 minutes in the 
absence (control) or presence of KN93 
and analysed for K63-linked 
ubiquitination of GABA B receptor by 
in situ PLA using antibodies directed 
against GABA B1 and K63-linked 
ubiquitin (white dots in representative 
images (scale bar: 5 μm). Right, 
quantification of in situ PLA signals. 
The data represent the mean ± SD of 
33 (control) and 30 (KN93) neurons 
from two independent experiments. ** 
p< 0.01, two-tailed unpaired t-test. 
B, C, CaMKIIβ promotes Ly-63-linked 
ubiquitination of GABA B receptors. 
Neurons were transfected with either 
CaMKIIα or CaMKIIβ or their 
functionally inactive mutants 
CaMKIIα(DN) or CaMKIIβ(DN). 
After two days, GABA B receptors 
were tested for Lys-63-linked (B) or 
Lys-48-linked (C) ubiquitination by in 
situ PLA using antibodies directed 
against GABA B1  and Lys-63 or Lys-48 
ubiquitin. Left, representative images 
depicting PLA signals (white dots, 
scale bars: 5 μm). Right, quantification 
of PLA signals. The data represent the 
mean ± SD of 17-21 neurons from two independent experiments. **** p< 0.0001; two-tailed unpaired t-test. 
We recently identified in GABAB1 several lysine residues (Lys-697/698, Lys-892 and Lys-
960) that are substrates for Lys-63-linked ubiquitination and important for targeting the 
receptors to lysosomal degradation (Zemoura et al., 2016). To further substantiate the finding 
that CaMKII regulates lysosomal degradation of GABAB receptors by promoting Lys-63-
linked ubiquitination of GABAB1, we tested whether blocking CaMKII affects cell surface 
expression of three GABAB1a(K->R) mutants in which Lys-697/698, Lys-892 and Lys-960 
were mutated to arginine (GABAB1a(K697/698R), GABAB1a(K892R) and 
GABAB1a(K960R)). In contrast to receptors containing wild type GABAB1, which displayed 
increased cell surface expression upon treatment with KN63 (GABAB1: 164 ± 149%, 
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Fig 5. Blocking CaMKII did not affect 
the expression levels of GABAB1a (K-
>R) mutants. 
 Neurons were transfected with HA-
tagged wild type GABA B1a or HA-tagged 
GABA B1a (K->R) mutants along with 
GABA B2 and tested for cell surface 
expression of GABA B1 and GABA B2  
after treating the neurons with 10 μM 
KN93 for 7.5 minutes. Left, 
representative images of untreated 
neurons (control, left panels) and of 
neurons treated with KN93 (right panels, 
scale bar: 5 μm). The corresponding 
graphs show the quantification of 
fluorescence signals. The fluorescence 
intensity of neurons transfected with wild 
type GABA B1 from untreated neurons 
(control) was set to 100%. The data 
represent the mean ± SD of 45-60 
neurons per experimental condition 
derived from three independent 
experiments. Please note that the 
considerably lower increase in GABA B2  
cell surface expression as compared with 
mutant GABA B1 was due to the fact that 
in case of GABA B1  only transfected 
subunits were detected (HA-tagged) but 
in the case of GABA B2  transfected as 
well as endogenously expressed subunits 
were detected. *** p< 0.001, two-tailed 
unpaired t-test. 
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Fig 6. Phosphorylation of GABAB1 Ser-867 controls cell surface expression and Lys-63-linked 
ubiquitination of GABAB  receptors. 
A, CaMKIIβ phosphorylates GABA B1 at Ser-867. HEK293 cells were transfected either with GABA B1 /GABA B2
with or without CaMKIIβ or with GABA B1 (S867A)/GABA B2 and CaMKIIβ. Two days after transfection, the 
cells were tested for serine phosphorylation by in situ PLA using antibodies directed against GABA B1 and 
phosphoserine. Left, representative images (scale bar: 10 µm, wt: wild type). Right, quantification of PLA 
signals (white dots in images). The PLA signals were normalized to the cell area as well as to the expression 
level of GABA B1 . The data represent the mean ± SD of 50 cells from two independent experiments. ns p> 0.05, 
*** p< 0.001; one way ANOVA, Dunnett’s Multiple Comparison test.  
B, C, Inactivation or constitutively mimicking phosphorylation of GABA B1  Ser-867 affects cell surface 
expression (B) as well as Lys-63-linked ubiquitination (C) of the receptors. Neurons were transfected with wild 
type HA-tagged GABA B1a (control), with the phosphorylation deficient HA-tagged GABA B1a(S867A) mutant or 
with the phosphomimetic HA-tagged GABA B1a(S867D) mutant along with GABA B2  and tested for cell surface 
expression using HA antibodies (B) as well as for Lys63-linked ubiquitination by in situ PLA with HA and 
GABA B1 antibodies (C). Left, representative images (scale bars: 5 μm). Right, quantification of fluorescence 
intensities (B) and PLA signals (C). The data represent the mean ± SD of 23-27 (B) and 18-20 neurons (C) from 
two independent experiments. * p< 0.05, *** p< 0.001; one way ANOVA, Dunnett’s Multiple Comparison test. 
 We previously showed that Lys-63-linked ubiquitination of GABAB1 is mediated by the 
ubiquitin E3 ligase MIB2 (Zemoura et al., 2016). We therefore tested for the involvement of 
MIB2 in CaMKIIβ-induced down-regulation of GABAB receptors. Overexpression in 
neurons of MIB2 or CaMKIIβ  reduced cell surface expression of GABAB receptors to a 
similar extent (MIB2: 40 ± 16%, CaMKIIβ: 45 ± 17% of EGFP transfected control neurons; 
Fig. 7A). Co-transfection of MIB2 and CaMKIIβ  in neurons did not further increase down-
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Fig 7. The ubiquitin E3 ligase MIB2 
is involved in CaMKIIβ-mediated 
regulation of cell surface GABAB  
receptors. 
A, Overexpression of MIB2 in 
addition to CaMKII does not enhance 
down-regulation of cell surface 
GABA B receptors. Neurons were 
transfected with the indicated plasmid 
and tested for cell surface expression 
of GABA B receptors using GABA B2
antibodies two days after transfection. 
Co-expression of MIB2 did not further 
enhance downregulation of cell 
surface receptors, indicating the 
involvement in the same pathway. 
Upper panels show representative 
images (scale bars: 5 μm). The graphs 
depict quantification of the 
fluorescence signals. The data 
represent the mean ± SD of 30 
neurons per condition derived from 
two independent experiments. ns p> 
0.05, *** p< 0.001; one way ANOVA, 
Bonferroni’s Multiple Comparison 
test. 
B, MIB2-induced down-regulation of 
cell surface receptors depends on 
phosphorylation of GABA B1 Ser-867. 
Neurons were transfected with wild 
type HA-tagged GABA B1a (control), 
with the phosphorylation deficient 
HA-tagged GABA B1a(S867A) mutant 
or with the phosphomimetic HA-
tagged GABA B1a(S867D) mutant 
along with GABA B2  and with or 
without MIB2. Two days after 
transfection, neurons were tested for 
cell surface expression of tagged 
GABA B1 using HA antibodies. Upper 
panels show representative images 
(scale bars: 5 μm). The graph depicts 
quantification of the fluorescence 
signals. The data represent the mean ± 
SD of 30 neurons per condition 
derived from two independent 
experiments. ns p> 0.05, *** p< 
0.001; one way ANOVA, 
Bonferroni’s Multiple Comparison test. 
C, GABA B1  phospho-mutants display altered MIB2 interaction. HEK 293 cells were transfected with wild type 
GABA B1 , GABA B1 (S867A) or GABA B1 (S867D) together with GABA B2  and MIB2. Two days after 
transfection, cells were analysed for interaction of GABA B receptors with MIB2 by in situ PLA using antibodies 
directed against GABA B1 and MIB2. Upper panels show representative images (scale bar: 10 μm). The graph 
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Fig 8. Glutamate-induced down-regulation of GABAB  receptors is mediated by GABAB1 Ser-867 
phosphorylation induced Lys-63-linked ubiquitination. 
A, B, Neurons transfected with wild type HA-tagged GABA B1a, with the phosphorylation deficient HA-tagged 
GABA B1a(S867A) mutant or with the phospho-mimetic HA-tagged GABA B1a(S867D) mutant along with 
GABA B2 were incubated for 60 min in the absence (control) or presence of 50 μM glutamate. Neurons were 
analysed for cell surface expression of transfected GABA B1  using HA antibodies (A) or analysed for Lys-63-
linked ubiquitination by in situ PLA using HA and GABA B1  antibodies (B). Upper panels show representative 
images (scale bars: 5 μm). The graphs depict quantification of the fluorescence signals (A) and in situ PLA 
signals (B). The data represent the mean ± SD of 28-30 (A) and 28-36 (B) neurons per condition derived from 
three independent experiments. ns p> 0.05, * p< 0.05, ** p< 0.01, *** p< 0.001, **** p< 0.0001; one way 
ANOVA, Bonferroni’s Multiple Comparison test.  
 
 
 
 
